Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones
AssigneeInspire Pharmaceuticals, Inc.
InventorsJonathan B. DeCamp, Paul S. Watson, Jin She
Life of this patent
Estimating the term…
Abstract
The present invention is directed to practical high-yielding synthetic processes for preparing 3,4-disubstituted-thiazolidin-2-ones, which do not compromise the absolute stereochemical integrity of the compounds. The present invention is also directed to novel compounds of 3,4-disubstituted-thiazolidin-2-ones. The compounds prepared by the present invention are useful in the synthesis and manufacture of compounds (such as latrunculins and/or their analogs) for treating diseases or conditions associated with inhibiting actin polymerization.
Claims7
A process for preparing a compound of Formula II,
- comprising the step of reacting a compound of Formula III with a reducing agent,
- wherein R is alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, heteroaralkyl, or heteroaryl, with or without substitution;
- A is alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, —CO2H, —CO2R4, —(CH2)nOR5, CHO, or CN, with or without substitution;
- R4 is alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, heteroaralkyl, or heteroaryl, with or without substitution;
- R5 is H, alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, or Si(R6)3, with or without substitution;
- R6 is alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, or OR7, with or without substitution;
- R7 is alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, heteroaralkyl, heteroaryl, with or without substitution;
- and
- n is an integer from 1 to 5.
Dependencies are inferred from the claim text.